Aimei Health Technology Co., Ltd
Status: Live Deal
U=S+R
R=S/5
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Dec 4, 2023 |
| CEO | Mr. Junheng Xie |
| Left Lead | Spartan Capital |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 1 + 1 + 1 + 1 + (8*1) |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | United Hydrogen Group Inc. |
| Deal Announced | Jun 20, 2024 |
| Deal Size, $M | $1,600.00M |
| Deal Sector | Energy |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Feb 5, 2025 |
AFJK
AFJKU
AFJKR
| Price | $11.03 |
|---|---|
| Last closing price | $10.97 |
| H/L, today | $11.03 / $11.03 |
| Volume, today | 3,401 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.